The onset of hyperammonemia due to the flow of ammonia-rich portal vein blood through a portalsystemic shunt causes a type of encephalopathy known as chronic portal-systemic shunt encephalopathy (CPSE). We herein report two cases of CPSE that presented with opposite changes in the blood ammonia concentrations during hemodialysis. It is curious that the encephalopathy was ameliorated by hemodialysis in case 1, but not case 2. Therefore, it is necessary to recognize CPSE and assess the blood ammonia concentrations in dialysis patients who develop a disturbance of consciousness, even if the serum transaminase level is normal.
Introduction
Hepatic encephalopathy (HE) usually occurs due to metabolic dysfunction of the liver, and the principal cause of encephalopathy is hepatic cirrhosis (1) . However, HE may occasionally occur in patients with a portal-systemic shunt (PSS) in the absence of intrinsic liver disease (1) . In addition, the development of hyperammonemia due to the flow of ammonia-rich portal vein (PV) blood through the PSS causes a form of encephalopathy known as chronic portalsystemic shunt encephalopathy (CPSE) (2) . It is difficult to diagnose CPSE because the serum transaminase level is normal, with the exception of hyperammonemia. Recently, CPSE has been recognized to be a cause of disturbance of consciousness in patients receiving dialysis (3) (4) (5) (6) . Dialysis patients may develop CPSE for several reasons, including the growth of PSS due to fluid overload and an increase in back flow via the PSS as a result of hemodialysis-related fluid removal (7) (8) (9) .
We herein report two cases of CPSE in hemodialysis patients who presented with opposite changes in the ammonia concentration in the blood. It should be noted that hemodialysis does not always ameliorate CPSE, and the treatment depends on the patient's pathophysiological condition in each case. normalities, except for hyperammonemia and left gastric varices identified on ultrasonography. Conservative therapy, including restriction of dietary protein, the infusion of branched-chain amino acids and the oral administration of lactulose, was initiated and her symptoms improved. However, seven months later, the patient was again admitted to our hospital due to deterioration of the renal function and diagnosed with chronic kidney disease (CKD), the cause of which continued to remain unknown. The results of a physical examination performed on admission were as follows: height: 146.5 cm, body weight: 54.6 kg, blood pressure: 136/78 mmHg, pulse rate: 66 beats/ min. No significant findings were noted apart from a systolic ejection heart murmur. The laboratory data were positive for hepatitis C virus (HCV) antibodies and cryoglobulin; however, no liver damage or coagulation disorders were observed. After admission, the patient developed a disturbance of consciousness and hyperammonemia (NH3: 107 μmol/L; Table 1 ). Although the serum transaminase level was normal, ultrasonography and CT scans revealed a shunt between the left gastric and renal veins (Fig. 1A) . No findings suggestive of liver cirrhosis were detected, and regurgitation of ammonia-rich blood into the systemic circulation through the shunt was considered to be the cause of the disturbance of consciousness. Nevertheless, because the urine volume began to decrease, and it was difficult to determine whether the disturbance of consciousness was caused by uremia, and hemodialysis was initiated. Thereafter, the blood ammonia concentration decreased from 197 to 47 μmol/L and the patient's disturbance of consciousness was ameliorated. She continued to receive hemodialysis, with no further signs of HE.
Case 2
A 55-year-old man with end-stage kidney disease resulting from diabetic nephropathy had a long history of disturbance of consciousness. One year after the initiation of hemodialysis, he was admitted to our hospital for an investigation of repeated episodes of abnormal behavior after hemodialysis.
The findings of a physical examination performed on admission were as follows: height: 174.2 cm, body weight: 70.6 kg, blood pressure: 164/104 mmHg, pulse rate: 89 beats/min. The patient presented with a disturbance of consciousness and flapping tremors. Laboratory tests revealed hyperammonemia (NH3: 106 μmol/L); however, the serum transaminase level was normal, and no abnormalities of the liver function, such as cirrhosis or tumors, were observed on ultrasonography or CT, with the exception of a shunt between the splenic and left renal veins (Fig. 1B) . The shunt was considered to be the cause of his disturbance of consciousness, similar to that observed in case 1.
The patient's disturbance of consciousness was ameliorated with conservative therapy, including restriction of dietary protein, the infusion of branched-chain amino acids and the oral administration of lactulose and kanamycin, although the blood ammonia concentration increased from 168 to 276 μmol/L during hemodialysis and his symptoms continued to deteriorate after hemodialysis sessions. Sixteen days after admission, balloon-occluded retrograde transvenous obliteration (B-RTO) was performed using ethanolamine oleate and a micro-coil to occlude the shunt (Fig. 2) . The following day, the ammonia level decreased to 25 μmol/L, and no further signs of HE were observed.
Discussion
The present two cases of CPSE involved opposite changes in the blood ammonia concentration during hemodialysis. HE is a neuropsychiatric disturbance caused by severe liver disease that results in psychomotor, intellectual, cognitive, emotional, behavioral and fine motor dysfunction (10) . Although the etiology of HE is poorly understood, it is known that ammonia is a key toxin in patients with HE that may sensitize the brain to various precipitating factors (10) . Moreover, it is widely accepted that the primary cause of HE is hepatic cirrhosis, although hyperammonemia is also observed in some patients without severe liver disease (1). Hyperammonemia follows either the increased production or decreased elimination of ammonia (1) . The onset of hyperammonemia due to the flow of ammonia-rich portal venous blood through the PSS is caused by a decrease in the elimination of ammonia; this condition is called CPSE (2) .
PSS is morphologically classified into five types according to whether the PSSs are located inside and/or outside the liver (11) . Type I is an intrahepatic type that can be divided into three subtypes: diffuse, non-diffuse (trauma, surgery, a patent venous duct) and mixed type (Rendu-OslerWeber disease). Type II is an intra-and extrahepatic type in which the shunt originates from the umbilical portion of the PV and flows into the inferior vena cava (IVC). In many cases, the PSS originates from the left gastric vein, splenic vein or superior mesenteric vein and connects with the left renal vein or IVC (11) . This latter pattern is called Type III (extrahepatic type); both of the present two cases belong to this type. The shunt pattern of Type IV is the same as that observed in Type III, whereas the hepatic blood circulation is similar to that seen in cases of idiopathic portal hypertension. Type V is also an extrahepatic type, although the PV is absent (11) . Fig. 3 shows diagrams of the PSSs in the pre- (7), shunt formation due to adhesion following abdominal surgery (8) and non-cirrhotic portal hypertension (9) . However, the mechanisms underlying the development of PSS in patients without portal hypertension have not been thoroughly studied. In the present two cases, we suspected the presence of congenital shunts, because CPSE developed prior to the initiation of hemodialysis in each patient. Initially, the preexisting shunts grew due to the progression of CKD and continuation of fluid overload (12, 13) . Subsequently, both the hyperammonemia and HE deteriorated as a result of an increased ammonia-rich blood flow into the systemic circulation, reflecting the existence of a pressure gradient between the IVC and PV (IVC-PV pressure gradient).
In a previous study, the blood ammonia concentrations in hemodialysis patients without cirrhosis decreased after dialysis therapy (14) . The same phenomenon was confirmed in the current case 1, whereas the blood ammonia concentration increased after hemodialysis therapy in case 2. Yokoo et al. used Doppler ultrasonography to assess hemodialysis patients with cirrhosis and demonstrated that the PV flow regurgitates in a steady state. In addition, the authors identified the presence of a PSS to the IVC associated with an increased back flow during hemodialysis (15) . Hence, the blood volume of the systemic circulation is decreased by dialysis, and the IVC-PV pressure gradient may be small because the blood volume in the systemic circulation is increased before dialysis. However, during hemodialysis, the inner pressure of the IVC decreases after fluid removal, which allows ammonia-rich blood to flow into the systemic circulation due to the increased pressure gradient. Although the present patients did not have cirrhosis, the extent of regurgitation of the blood flow into the systemic circulation increased during hemodialysis. In case 1, dialysis removed ammonia from the blood at a greater rate than that being added by the increased shunt blood flow, and the patient's HE was always ameliorated after the dialysis session. In contrast, the blood ammonia level increased during dialysis in case 2, and HE did not occur after the dialysis session when the volume of blood removed via dialysis was less than 3.0 liters (dry weight of approximately 4%). This implies that the hemoconcentration resulting from fluid removal influences the onset of HE. However, the volume removed by dialysis was 1 to 2 liters (dry weight of 2-4%) in case 1, which was similar to that observed in case 2. The difference between the two cases may reflect differences in the blood flow volume due to the size of the shunt and changes in the IVC-PV pressure gradient. In addition to the amount of fluid removed, the systemic blood volume in dialysis patients is evaluated based on the change in blood pressure during dialysis. However, the intradialytic blood pressure remained stable in both cases. Moreover, transient metabolic alkalosis and hypokalemia due to hemodialysis may aggravate HE (16) . Therefore, CPSE is not always ameliorated by treatment with hemodialysis. Table 2 summarizes previous reports of CPSE in dialysis patients (3-7, 12, 13, 15, 17-19) . While most cases have been reported in Japan, it is unclear whether CPSE is more prevalent in Japan than in other countries. The average age of CPSE patients is 63.3 years, and the male-female ratio is 7:5. The initial symptom is usually a disturbance of consciousness, developing before or within two years after the initiation of dialysis therapy, although, in some cases, CPSE may develop more than 10 years after the start of dialysis. Most shunts connect the left gastric vein or splenic vein with the left renal vein. In a few cases, CPSE is ameliorated with conservative therapy; however, B-RTO or surgical ligation of the shunt is often performed. Including the present patients, only seven cases have been reported with assessments of symptom changes after hemodialysis. Among these patients, dialysis improved symptoms in three (13, 17, case 1) and exacerbated symptoms in the others (4, 15, 18, case 2). Treatment for CPSE typically involves either conservative therapy (restriction of dietary protein, infusion of branchedchain amino acids and oral administration of lactulose and kanamycin) or blocking of the shunt flow. Due to the effects of cirrhosis of the liver, conservative therapy is the same as that for HE, and if the rate of removal of blood ammonia during dialysis is greater than the rate of addition of ammonia by the shunt blood flow, as noted in case 1, hemodialysis can be used to treat CPSE. A poor improvement of CPSE with conservative therapy warrants the consideration of blockage of the shunt flow using either surgical ligation (20) or embolization of the shunt (B-RTO) (21) . B-RTO is less invasive than surgical ligation and is often chosen for this reason.
In conclusion, it is important to recognize that fluid overload in CKD patients is a risk factor for the growth of congenital PSS and that hemodialysis-related fluid removal may increase the ammonia-rich blood flow from the PV into the systemic circulation. Diagnosing CPSE is difficult in these cases, as the serum transaminase level is normal although the ammonia concentration is high. In addition, it is critical to recognize that encephalopathy is ameliorated by hemodialysis in some cases and exacerbated in others. Hence, investigating the cause of CPSE and determining the blood ammonia concentration is recommended in dialysis patients with a disturbance of consciousness.
